跳转至内容
Merck
CN

Optimization of

Oncotarget (2017-12-22)
Marius Ilie, Catherine Butori, Sandra Lassalle, Simon Heeke, Nicolas Piton, Jean-Christophe Sabourin, Virginie Tanga, Kevin Washetine, Elodie Long-Mira, Priscilla Maitre, Nathalie Yazbeck, Olivier Bordone, Virginie Lespinet, Sylvie Leroy, Charlotte Cohen, Jérôme Mouroux, Charles Hugo Marquette, Véronique Hofman, Paul Hofman
摘要

Treatment with EGFR inhibitors is limited to patients with advanced/metastatic non-small cell lung cancer who have known